Patents Represented by Attorney M. C. Sudol, Jr.
  • Patent number: 4645094
    Abstract: A fluid dispenser for dispensing liquid detergents, soaps and germicides. A pressure plate imparts a squeezing force to a flexible reservoir containing the liquid material to force the material therefrom. A battery operated photoelectric device is positioned adjacent the dispensing valve which is opened for a timed period upon locating an object such as a hand, near the photoelectric device. Also, a device is provided to control the power to the photoelectric device upon sensing the condition of the ambient room lighting.
    Type: Grant
    Filed: January 31, 1986
    Date of Patent: February 24, 1987
    Assignee: Calgon Corporation
    Inventors: John R. Acklin, Lee W. Bush, Joseph J. Danna, John L. Devitt, George A. Rauh
  • Patent number: 4634532
    Abstract: The instant invention is directed to a process for the control of scale formation and deposition in thermal or reverse osmosis membrane desalination plants, comprising adding to the water 0.1 to 100 ppm of (a) a water soluble orthophosphate and (b) at least one compound selected from the group consisting of water soluble polycarboxylates, phosphonates, phosphates, sulfonates and polyamides.
    Type: Grant
    Filed: September 25, 1985
    Date of Patent: January 6, 1987
    Assignee: Calgon Corporation
    Inventors: Douglas P. Logan, Thomas E. Cornelius, III, Susan P. Rey
  • Patent number: 4632954
    Abstract: This invention is directed to a method of improving the heat aging properties of a halogen-containing rubber comprising adding an effective amount of a compound selected from the group consisting of aromatic amino acids, related compounds, and salts of hydroxy benzoic acid to said halogen-containing rubber prior to vulcanization, and then vulcanizing.
    Type: Grant
    Filed: June 27, 1985
    Date of Patent: December 30, 1986
    Assignee: Calgon Corporation
    Inventor: Albert J. Dalhuisen
  • Patent number: 4575425
    Abstract: The instant invention is directed to a composition useful for inhibiting precipitation of calcium oxalate in aqueous systems comprising: (a) a water soluble phosphate, phosphonate or phosphinate; and (b) a water soluble polyelectrolyte wherein the ratio of component (a) to component (b) ranges from 10:1 to 1:10.The instant invention is further directed to a method of inhibiting the precipitation and deposition of calcium oxalate scale in an aqueous system, comprising adding to said system an effective amount of the above described composition, wherein said aqueous system has a pH greater than or equal to 2.0.
    Type: Grant
    Filed: December 24, 1984
    Date of Patent: March 11, 1986
    Assignee: Calgon Corporation
    Inventors: Bennett P. Boffardi, John P. Farkas, Monica A. Yorke
  • Patent number: 4425337
    Abstract: A method and drug form enhancing the rate of absorption of a rectally administered drug from the rectal compartment into the blood stream of a warm blooded animal. The method includes the steps of preparing a drug form capable of being rectally administered. The drug form comprises a therapeutically effective unit dosage amount of a selected drug of the type which is capable of being absorbed into the blood stream from the rectal compartment and phenothiazines or salts thereof being present in the drug form in a sufficient amount to be effective in enhancing the drug absorption rate, when rectally administering the drug form to warm blooded animals.
    Type: Grant
    Filed: December 30, 1981
    Date of Patent: January 10, 1984
    Assignee: Merck & Co., Inc.
    Inventors: Jose Alexander, Joseph A. Fix
  • Patent number: 4412994
    Abstract: Novel prodrug forms of known non-steroidal anti-inflammatory agents are disclosed, said prodrugs having the structural formula ##STR1##
    Type: Grant
    Filed: May 28, 1982
    Date of Patent: November 1, 1983
    Assignee: INTERx Research Corporation
    Inventors: Kenneth B. Sloan, Roy Little
  • Patent number: 4406896
    Abstract: A method and drug form for enhancing the rate of absorption of a rectally administered drug from the rectal compartment into the blood stream of a warm blooded animal. The method includes the steps of preparing a .beta.-lactam drug form capable of being rectally administered. The drug form comprises a therapeutically effective unit dosage amount of a selected drug of the type which is capable of being absorbed into the blood stream from the rectal compartment and hydroxy aryl or hydroxy aralkyl acids or salts, amides or esters thereof, the hydroxy aryl or hydroxy aralkyl acids or salts, amides or esters thereof being present in the drug form in a sufficient amount to be effective in enhancing the drug absorption rate, when rectally administering the drug form to warm blooded animals.
    Type: Grant
    Filed: June 25, 1981
    Date of Patent: September 27, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Takeru Higuchi, Toshiaki Nishihata, Howard J. Rytting
  • Patent number: 4291050
    Abstract: This invention relates to a new class of chemical compounds which can be described generally as 6,7-disubstituted-2 or 2,2-substituted-5-substituted-1-indanones. These compounds are effective diuretic and saluretic agents.
    Type: Grant
    Filed: June 21, 1979
    Date of Patent: September 22, 1981
    Assignee: Merck & Co., Inc.
    Inventors: Otto W. Woltersdorf, Jr., Edward J. Cragoe, Jr.